News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

£20 Million Financing For Sanger Institute Spin-Out Kymab



7/13/2010 8:16:47 AM

Pharma Times -- The Wellcome Trust’s investment division has agreed a £20 million Series A equity financing for Kymab, a biopharmaceutical company spun out from the Trust’s Sanger Institute in Cambridge, UK and focused on the discovery, development and commercialisation of novel antibody-based medicines.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES